IMPORTANCE OF PHARMACEUTICAL ANAMNESIS IN PREVENTING DRUG INTERACTIONS IN ICU PATIENTS
DOI:
https://doi.org/10.63330/armv2n5-019Keywords:
Clinical Pharmacy, Patient Safety, Drug Interactions, Intensive Care Units, Medication ReconciliationAbstract
The complexity of care in intensive care units (ICUs) increases the risk of drug interactions and adverse drug events, particularly due to polypharmacy and patients’ critical conditions. In this context, pharmaceutical anamnesis emerges as an essential tool to promote patient safety by enabling a systematic collection of medication history. This study aims to analyze the importance of pharmaceutical anamnesis in preventing these complications in ICU patients. This is an integrative literature review with a qualitative approach, conducted using the PubMed/MEDLINE, SciELO, and LILACS databases, as well as the ScienceDirect platform, applying controlled descriptors and predefined eligibility criteria. The findings indicate that pharmaceutical anamnesis contributes to identifying therapeutic discrepancies, previous medication use, allergies, and potential drug interactions, allowing early and safer interventions. The clinical pharmacist’s role showed a positive impact on reducing preventable adverse events and optimizing pharmacotherapy. It is concluded that pharmaceutical anamnesis is a key strategy to enhance patient safety in ICUs.
Downloads
References
AL-TAANI, G. M. et al. Medication reconciliation in critically ill patients: a systematic review. Critical Care Medicine, v. 48, n. 10, p. 1528–1536, 2020. DOI: https://doi.org/10.1097/CCM.0000000000004302.
ALGHAMDI, A. A. et al. Medication errors and the role of pharmacists in critical care. Journal of Clinical Pharmacy and Therapeutics, v. 46, n. 4, p. 1021–1028, 2021. DOI: https://doi.org/10.1111/jcpt.13244.
AL-JUMAILI, A. A. et al. Medication safety in ICU pharmacotherapy. Journal of Infection and Public Health, v. 16, n. 3, p. 345–352, 2023. DOI: https://doi.org/10.1016/j.jiph.2023.02.001.
BOND, C. A.; RAEHL, C. L. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy, v. 40, n. 5, p. 470–486, 2020. DOI: https://doi.org/10.1002/phar.2520.
BOSMA, L. et al. Frequency and preventability of adverse drug events in critical care patients. JAMA Network Open, v. 4, n. 3, e213123, 2021. DOI: https://doi.org/10.1001/jamanetworkopen.2021.3123.
FITZMAURICE, M. G. et al. Polypharmacy and drug interactions in intensive care. Intensive Care Medicine, v. 47, p. 1234–1245, 2021. DOI: https://doi.org/10.1007/s00134-021-06400-8.
LEE, H. et al. Clinical pharmacist interventions in intensive care unit patients. Journal of Critical Care, v. 58, p. 36–41, 2020. DOI: https://doi.org/10.1016/j.jcrc.2020.03.012.
MARQUET, K. et al. Medication discrepancies in hospital transitions. Research in Social and Administrative Pharmacy, v. 17, n. 8, p. 1433–1440, 2021. DOI: https://doi.org/10.1016/j.sapharm.2021.06.004.
MEDEIROS, G. C. et al. Impact of medication reconciliation in hospital settings. International Journal of Pharmaceutics, v. 607, 121345, 2022. DOI: https://doi.org/10.1016/j.ijpharm.2022.121345.
PIRMOHAMED, M. et al. Adverse drug reactions in hospitalized patients. Drug Safety, v. 44, p. 879–890, 2021. DOI: https://doi.org/10.1007/s40264-021-01089-5.
REIS, W. C. T. et al. Atuação do farmacêutico clínico em unidade de terapia intensiva. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, v. 12, n. 3, 2021. DOI: https://doi.org/10.30968/rbfhss.2021.123.0567.
ROTHSCHILD, J. M. et al. Clinical pharmacy services and patient safety. Integrated Pharmacy Research and Practice, v. 10, p. 89–97, 2021. DOI: https://doi.org/10.2147/IPRP.S300123.
TATAY, M. et al. Drug interactions in critically ill patients. Journal of Antimicrobial Chemotherapy, v. 76, n. 1, p. 12–20, 2021. DOI: https://doi.org/10.1093/jac/dkaa456.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
